Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 1 hr 3 mins

S&P Futures
5,874.25
-22.00(-0.37%)
Dow Futures
43,044.00
-133.00(-0.31%)
Nasdaq Futures
20,433.75
-85.75(-0.42%)
Russell 2000 Futures
2,244.40
-11.10(-0.49%)
Crude Oil
71.18
+0.62(+0.88%)
Gold
2,748.60
+9.70(+0.35%)

Quantum BioPharma Ltd. (QNTM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Follow

6.81

-0.74

(-9.80%)

At close: 04:00PM EDT

7.29

+0.48

(+7.05%)

Pre-Market:

08:26AM EDT

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	11.65M
Enterprise Value	8.95M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	91.86
Price/Book (mrq)	1.15
Enterprise Value/Revenue	98.56
Enterprise Value/EBITDA	-1.57

Trading Information

Stock Price History

Beta (5Y Monthly)	0.83
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	97.50
52 Week Low ³	3.50
50-Day Moving Average ³	4.50
200-Day Moving Average ³	25.87

Share Statistics

Avg Vol (3 month) ³	518.27k
Avg Vol (10 day) ³	104.3k
Shares Outstanding ⁵	1.86M
Implied Shares Outstanding ⁶	N/A
Float ⁸	1.07M
% Held by Insiders ¹	13.73%
% Held by Institutions ¹	1.50%
Shares Short (Sep 30, 2024) ⁴	95.09k
Short Ratio (Sep 30, 2024) ⁴	0.65
Short % of Float (Sep 30, 2024) ⁴	5.38%
Short % of Shares Outstanding (Sep 30, 2024) ⁴	5.12%
Shares Short (prior month Aug 30, 2024) ⁴	124.32k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	-36.12%
Return on Equity (ttm)	-63.89%

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-10.06M
Net Income Avi to Common (ttm)	-7.47M
Diluted EPS (ttm)	-13.00
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	3.33M
Total Cash Per Share (mrq)	2.56
Total Debt (mrq)	625.2k
Total Debt/Equity (mrq)	6.13
Current Ratio (mrq)	1.99
Book Value Per Share (mrq)	15.02

Cash Flow Statement

Operating Cash Flow (ttm)	-5.14M
Levered Free Cash Flow (ttm)	-9.99M